Prescriber's Choice

Prescriber's Choice, now operating under the unified brand SKNV, is a healthcare company that provides customized dermatological medications through a unique physician-dispensing model. The company operates an FDA-registered 503B outsourcing facility, Sincerus Florida, which manufactures high-quality compounded formulations tailored to specific patient needs as determined by their doctors. Their platform allows dermatologists to dispense these medications directly at the point of care, bypassing traditional retail pharmacy hurdles and insurance prior authorization processes. By focusing on the 12 most common dermatological diagnoses, Prescriber's Choice aims to improve patient adherence and outcomes while reducing the administrative burden on medical practices. The company is backed by private equity firms including Accelmed Partners and Decathlon Capital Partners.